Rajappa S. Kenchappa

Jacksonville College — United States

Medicine · Health Sciences

30h-index2.8kcitations120works2.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(35), Glioma Diagnosis and Treatment(19), Cancer, Hypoxia, and Metabolism(19), Synthesis and biological activity(14), Nerve injury and regeneration(11)

Publications119 total

EXTH-18. MT-125 Inhibits Non-Muscle Myosin IIA and IIB and Prolongs Survival in Glioblastoma
Neuro-Oncology·2025Open Access
MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma
Cell·2025· 13 citedOpen Access
Resistance to spindle inhibitors in glioblastoma depends on STAT3 and therapy induced senescence
iScience·2024· 1 citedOpen Access
TMIC-67. EMERGING ROLE OF EXTRACELLULAR MATRIX STIFFNESS AS A HALLMARK OF GLIOBLASTOMA: INSIGHT TO MECHANICAL MEMORY FORMATION AND PROLONGED INVASION IN THE TUMOR PERIPHERY
Neuro-Oncology·2024· 1 citedOpen Access
CSIG-03. MT-125 INHIBITS NON-MUSCLE MYOSIN IIA AND IIB, SYNERGIZES WITH ONCOGENIC KINASE INHIBITORS, AND PROLONGS SURVIVAL IN GLIOBLASTOMA
Neuro-Oncology·2024Open Access
Virtual Clinical Trials of BMP4 Differentiation Therapy: Digital Twins to Aid Successful Glioblastoma Trial Design
2024Open Access
Resistance to Spindle Inhibitors in Glioblastoma Depends on STAT3 and Therapy Induced Senescence
2024Open Access
MT-125 Inhibits Non-Muscle Myosin IIA and IIB, Synergizes with Oncogenic Kinase Inhibitors, and Prolongs Survival in Glioblastoma
2024· 2 citedOpen Access
Bovine Serum Albumin (BSA) Mediated Efficient One Pot Synthesis of 3,3′-(Phenylmethanediyl)bis(4-hydroxy-6-methyl-2H-pyran-2-one) Derivatives and Their Biological Studies
Russian Journal of Bioorganic Chemistry·2023
DDDR-15. RESISTANCE TO TARGETED ANTI-MITOTICS IN GLIOBLASTOMA IS DRIVEN BY STAT3 ACTIVATION AND THERAPY INDUCED SENESCENCE
Neuro-Oncology·2023· 1 citedOpen Access
Supplementary Figure 7 from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
Supplementary Figure 2 from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
Supplementary Figure Legends from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
Supplementary Figure Legends from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
Supplementary Figure 6 from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
Supplementary Methods from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
Supplementary Table S3 from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
Supplementary Figure 4 from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
Supplementary Figure 2 from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
Supplementary Figure 1 from RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Yadav D. Bodke(11), Bruce Carter(10), Peter Forsyth(8), Sandeep Telkar(8), Susanne Schlisio(6), Vijayalakshmi Ravindranath(6), M. Aruna Sindhe(6), Steven S. Rosenfeld(6), Arnold B. Etame(4), Latha Diwakar(4), Athanassios Dovas(4), Amanda Luu(4), Rita West(4), Peter Canoll(4), Karin Wallis(4), Wilma Friedman(3), Alexandra Pisklakova(3), Jayasree Annepu(3), A. Chandrashekar(3), James F. Crish(3)